Neogen’s GeneQuence assays for Salmonella, Listeria, and L. monocytogenes combine the superior specificity of DNA hybridization technology with the ability to rapidly process a few samples, or up to 372 samples at once.
Neogen’s Reveal line of lateral flow microbial tests for E. coli O157:H7,
Salmonella and Listeria allows users to quickly and accurately screen samples
for these pathogens. Reveal for E. coli O157:H7 utilizes Neogen’s proprietary
media to allow users to screen samples for this pathogen in as little as 8 hours.
For more information visit www.neogen.com.
Latest from Quality Assurance & Food Safety
- FDA, CDC Investigate Salmonella Outbreak Linked to Live It Up Dietary Supplement Powder
- USDA FSIS Announces New Deputy Administrator of Field Operations
- ProVeg Incubator Launches Fast-Track to Impact Program for Alt-Protein Startups
- Kerry Releases 2026 Global Taste Charts
- FDA Shares Australia Certificate Requirements for Bivalve Molluscs and Related Products
- FDA Announces Update from CFIA on Certificate Requirements for Certain Meat, Poultry Products
- NIMA Partners Introduces the Next-Generation NIMA Gluten Sensor
- IFT to Host Community Conversation on Dietary Guidelines for Americans, 2025-2030 Report
